| Serial Number | 98137948 |
| Word Mark | ALLIANCE CLINICAL NETWORK |
| Filing Date | Thursday, August 17, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, October 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 22, 2024 |
| Description of Mark | The mark consists of an X-like element formed of a single line that loops back on itself in gradients of green and blue, which includes a central square and is surrounded by four circles, the left and right circles being green and the top and bottom circles being blue, all to the left of the words ALLIANCE in all blue caps stacked above the words CLINICAL NETWORK in smaller title case in blue. The color white represents background and/or transparent area and is not claimed as a part of the mark. |
| Indication of Colors claimed | The color(s) blue and green is/are claimed as a feature of the mark. |
| NOT AVAILABLE | CLINICIAL NETWORK |
| Goods and Services | Testing of pharmaceuticals; Medical and scientific research services, namely, the provision of clinical trial services to biopharmaceutical companies in support of pharmaceutical product development; Medical research and scientific laboratory services for others, namely, the provision of clinical trial services to biopharmaceutical companies in support of pharmaceutical product development; Pharmaceutical and Scientific research and development services; Pharmaceutical products development; Pharmaceutical drug development services; Clinical research in the nature of scientific research in the field of medicine, therapeutics and pharmaceutical development, namely, psychiatry, neurology, analgesia, metabolic diseases and disorders, endocrinology, dermatology, infectious diseases, and women's health; Scientific research services, namely, conducting clinical trials for biopharmaceutical companies in support of pharmaceutical product development; Drug discovery services; Consulting services in the field of pharmaceutical research and development; research and development services in the fields of psychiatry, neurology, analgesia, metabolic diseases and disorders, endocrinology, dermatology, infectious diseases, and women's health, namely, the provision of clinical trial services to biopharmaceutical companies in support of pharmaceutical product development; scientific research consulting services for biopharmaceutical companies in the field of design, planning, and implementation project management of clinical trials in support of pharmaceutical product development |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, September 16, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, April 19, 2019 |
| First Use In Commerce Date | Friday, April 19, 2019 |
| Party Name | Alliance Clinical, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Dallas, TX 75230 |
| Party Name | Alliance Clinical, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Dallas, TX 75230 |
| Event Date | Event Description |
| Saturday, September 16, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, April 17, 2024 | ASSIGNED TO EXAMINER |
| Monday, April 22, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, April 22, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 22, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, August 21, 2023 | NEW APPLICATION ENTERED |
| Tuesday, September 19, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, July 1, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 1, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 1, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 8, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, August 8, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, August 8, 2024 | NON-FINAL ACTION E-MAILED |
| Saturday, August 17, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, August 17, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, August 17, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, September 16, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 2, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 22, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 22, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |